OUR VISION:

Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests

- Revenue guidance raised to $230-240 million for 2017, from $195-205 million- Guidance for Cologuard tests to be completed during 2017 increased to at least 550,000 tests, from at least 470,000- 11,000 additional providers ordered Cologuard for the first time during the second quarter, and insurance coverage expanded to 86 percent of target population MADISON, Wis., July 25,...Read more

Jerry Kelly and Exact Sciences Team Up to Promote Colon Cancer Screening

Golfer launches multi-year, Cologuard®-branded campaign MADISON, Wis., June 22, 2017 /PRNewswire/ -- Exact Sciences today announced it is teaming up with Madison professional golfer Jerry Kelly to help drive home the importance of colorectal cancer screening.  Beginning at this week's American Family Insurance Championship, Kelly will wear a Cologuard-branded hat for the next two years...Read more

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com